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was treated with an IMRS plan designed with the isocenter 
located at the target center (plan A). A second off-target 
isocenter plan (plan B) was generated for each case. In all 
plans the 100% of the prescription dose covered the 99% of 
the target volume. The plans A and B were compared for the 
target dosage (conformity and homogeneity indices) and 
organs at risk (OAR) dose sparing. Peripheral dose falloff was 
compared by using the metrics V12 (volume of normal brain 
receiving more than 12 Gy) and CI 50% (conformity index at 
the level of the 50% of the prescription dose). 
 
Results: The values found for each metric (plan B vs. plan A) 
were (mean ± SD): CI (1.28 ± 0.15 vs. 1.28 ± 0.15, p = 0.978), 
HI (1.29 ± 0.14 vs. 1.34 ± 0.17, p = 0.079), maximum dose to 
brainstem (2.95 ± 2.11 vs. 2.89 ± 1.88 Gy, p = 0.813); 
maximum dose to optical pathway (2.65 ± 4.18 vs. 2.44 ± 
4.03 Gy, p = 0.195) and maximum dose to eye lens (0.33 ± 
0.73 vs. 0.33 ± 0.53 Gy, p = 0.970). The values of the 
peripheral dose falloff were (plan B vs. plan A): V12 (5.98 ± 
4.95 vs. 6.06 ± 4.92 cm3, p = 0.622), and CI 50% (6.08 ± 2.77 
vs. 6.28 ± 3.01, p = 0.119). 
 
Conclusion: The off-target isocenter solution resulted in 
dosimetrically comparable plans as the center-target 
isocenter technique, by avoiding the risk of gantry-couch 
collision during the CBCT acquisition. 
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Purpose or Objective: The extraction of the data from DVH, 
with the aim of perform an analysis of a large number of 
patients in a research project, is a time-consuming process. 
Furthermore, in the case of Tomotherapy, the resolution 
obtained from the DVH is poor. This lack of resolution may 
suppose an additional source of error of this analysis. With 
the aim of solving these problems, we have developed an 
easy macro using the Microsoft Excel®, which allows 
performing the analysis of as many patients as you wish with 
a single click, improving the resolution and allowing the 
analysis of up to 7 structures in each histogram. 
 
Material and Methods: a. Input data: 1. The dose range 
displayed on the DVH has to be the same in all patients. 2. 
Up to 7 structures can be chosen in each patient, and the 
same structure has to be identified with the same color in all 
the analyzed patients. The seven colors that can be chosen 
are red, green, blue, cyan, yellow, magenta and black. 3. 
Thereafter, a screenshot of the DVH has to be saved. b. 
Programming: Macro in ImageJ: 1. Open the DVH in RGB 
format image. 2. Split images on the RGB channels. 3. One 
image is obtained for each structure once the image 
subtraction has been performed, obtaining one single 
histogram for each structure. 4. The line tool will allow 
obtain either the dose reached in a given volume or the 
volume enclosed in an isodose. 5. The macro generates a plot 
profile and a list of values, which are saved in an 
independent .xls archive. Macro in Excel: 1. Opens the .xls 
files generated by the ImageJ macro. 2. Opens the .xls files. 
3. Finds the maximum of every list. 4. Calculates the value of 
the histogram corresponding to this maximum. 5. Store this 
value in an .xls archive where all the data analyzed are 
stored. 
 
Results: I.e., in a case of prostate cancer with seven 
structures under study, a total of 16 items are analyzed: PTV 
prostate and PTV nodes: 98% and 2% of volume. Rectum: V50, 
V60, V65, V70 and V75. Bladder: V65, V70, V75 and V80. 
Femoral head (left and right): V50 Penile bulb: V90 a. Time 
per patient: Manual: 10 min Macro: 30 s (time necessary for 
the preparation of the histogram). b. Resolution: Manual: X 
axis (dose): 16,95 points per Gy. Y axis (% volume): 0,37 
points per 1% of volume. Macro: X axis (dose): 14,84 points 
per Gy. Y axis (% volume): 3,78 points per 1% of volume. 
 
Conclusion: This new macro is a powerful and user-friendly 
tool designed to help the investigators to perform a quicker 
data analysis, allowing to perform it up to ten times faster. 
This is especially useful in the case of analyzing structures 
with multiple control points, as is the case of rectum and 
bladder. Likewise, the results obtained with the macro 
provide a better resolution than measured data, specially, in 
the y-axis, where the resolution may be improved about ten 
times. These kind of macros may be programmed to obtain 
data from as many patients and as many values as desired in 
the seven structures of the DVH. 
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Purpose or Objective: The aim of this study was to evaluate 
and compare the non-coplanar IMRT and coplanar VMAT 
techniques for the treatment of patients with single brain 
metastasis and their influence on the absorbed dose by the 
OARs. 
 
Material and Methods: Treatment planning computed 
tomography (CT) scans of 6 patients with single brain 
metastasis who had received palliative whole brain 
radiotherapy (WBRT) with simultaneous integrated boost (SIB) 
was recruited. Each patient re-planned with 9 fields non-
coplanar IMRT and coplanar VMAT for dosimetric comparison. 
Details of the field arrangement in IMRT plan are presented 
in Table 1. Two coplanar full arcs by Varian Millennium 120 
MLCs were used in all VMAT plans. Arcs were arranged with 
30 degrees collimator to protect MLC leak. Prescribed WBRT 
dose was 30 Gy in 10 fractions and SIB dose was 39 Gy in 10 
fractions. Radiation doses to OARs and targets, conformity 
and homogeneity index and monitor units from two 
techniques were tested statistically by pared t-test 
considering significant level of p-value <0.05. 
Table 1. Details of the field arrangement for non-coplanar 
IMRT 
 
 
 
 
Beam Gantry Angle Collimator Angle  Couch Angle 
1 10 45 0 
2 60 45 0 
3 130 45 0 
4 170 45 0 
5 220 45 0 
6 270 45 0 
7 320 45 0 
8 290 0 90 
9 330 0 90 
 
Results: Median PTV30 and PTV39 was 1390 (range: 1110-
1810) and 18.3 (range: 2.9-45.6) cc. Radiation doses to both 
eyes were significantly higher in coplanar VMAT technique 
(p<0.05) (Table 2). There was no significant dose difference 
for both lens and targets between both techniques. Monitor 
unit was significantly higher in IMRT technique (median: 2076 
(range: 1759-2201) vs. 617 (range: 584-695), p<0.001). 
Table 2. Dose result comparisons of non-coplanar IMRT and 
coplanar VMAT 
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 IMRT  ARC  
 Median (Range) Median (Range) p 
Eye L maximum dose (Gy)  12.36 (8.30-15.70) 14.86 (13.22-17.73)  <0.05 
Eye L mean dose (Gy)  5.34 (4.42-6.40) 7.83 (7.27-9.66)  <0.05 
Eye R maximum dose (Gy)  11.53 (7.20-14.94)  14.81 (13.85-17.35) <0.05 
Eye R mean dose (Gy) 5.91 (4.33-6.60) 7.97 (7.66-9.02) <0.05 
Monitor Unit 2076 (1759-2201) 617 (584-695) <0.001 
 
Conclusion: Non-coplanar IMRT is superior to coplanar VMAT 
in sparing eye without of any worse results on targets. But, 
negative aspects of non-coplanar IMRT technique such as 
duration of treatment as a result of high MU values, can 
affect significantly negative in routine practice. 
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Purpose or Objective: This study investigated conformation 
number (CN), homogeneity index (HI), and doses to heart, 
ipsilateral lung, contralateral lung and breast from two 
distinct radiotherapy techniques for early left-sided breast 
cancer patients after lumpectomy. We compared volumetric 
modulated arc therapy (VMAT) and field-in-field (FiF). Both 
technique utilized hypofractionation with simultaneous 
integrated boost (SIB). 
 
Material and Methods: From archival CT scans, we selected 7 
situations: 4 tumor locations in upper-outer quadrant (the 
most common), 1 in upper-inner quadrant, 1 in lower-outer 
quadrant, and 1 in lower-inner quadrant. SIB provided 
differential dosing to the whole breast and the resection 
cavity at each fraction; hence reduced the number of 
treatment fractions. In both VMAT and FiF, fractionation 
schemes were 28 daily fractions of 1.8 Gy to the whole breast 
and 2.15 Gy to the tumor bed adding up to a total dose of 
60.2 Gy. They were biologically equivalent to the sequential 
boost-technique comprising 25 fractions of 2 Gy to the whole 
breast PTV followed by a boost irradiation in 6 fractions, 
using an alpha/beta ratio of 4 Gy for tumor response, based 
on the linear-quadratic cell survival model. Planning target 
volume (PTV)-breast and PTV-boost were defined by 
expanding whole breast isotropically by 5 mm and 3 mm, 
respectively. Dose volume constraints for ipsilateral lung: 
V20Gy < 20%, V5Gy < 40%; for contralateral lung: V5<5%; for 
contralateral breast: mean dose <3 Gy; for the heart: mean 
dose<10Gy and V20Gy < 15%. The goal was to encompass the 
PTV in all direction with the 95% isodose line, and volumes 
receiving higher than 110% of the prescribed dose were 
minimized. One experienced VMAT planner developed all 
VMAT plans while the other experienced FiF planner 
developed all FiF plans. The optimal CN is 1 since 
CN=(TV95%/TV)x(TV95%/V95%). The optimal HI is 0 since 
HI=(D2%-D98%)/D. CN, HI, and doses to normal tissues were 
compared by the Wilcoxon signed-rank test. 
 
Results: VMAT significantly improved both CN for PTV-boost 
(0.66 vs. 0.29) and PTV-breast (0.82 vs 0.55), HI for PTV-
breast (25.01 vs 32.54), mean dose to heart (4.08 vs 7.71), 
V20-heart (3.14 vs 13.12), V20-left lung (11.49 vs 24.29) and 
V5-left lung (31.54 vs 35.98), p = 0.018. The mean healthy 
breast dose was similar between VMAT and FiF (2.39 and 1.68 
Gy, respectively); and the HI for PTV-Boost was also similar 
between VMAT and FiF (10.95 and 13.72, respectively). 
However, FiF did better in sparing contralateral lung. The 
mean dose to contralateral lung by VMAT and FiF were 1.75 
Gy vs 0.46 Gy, respectively (p = 0.018). 
 
Conclusion: VMAT significantly improved conformity and 
homogeneity in hypofractionated SIB plans for breast cancer. 
Doses to heart and ipsilateral lung were significantly 
decreased, yet more contralateral lung received low doses 
that less than 2 Gy averagely. Doses to contralateral breast 
showed no difference between VMAT and FiF. 
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Purpose or Objective: To develop a volumetric arc therapy 
(VMAT) technique for delivering Total Marrow Irradiation 
(TMI) treatments at this institution using RapidArc™; to assess 
its benefits over the standard parallel-opposed technique, 
and evaluate the feasibility of delivering it. 
 
Material and Methods: 5 previously treated TMI patients 
were retrospectively planned with RapidArc™. The 
treatments were delivered as quality assurance (QA) plans 
and verified using the Octavius™ phantom and PTW™ 2D 
array. The conventional parallel-opposed technique was 
modelled in the Eclipse™ Treatment Planning System and the 
dose distributions compared with the RapidArc™ plans. 
 
Results: The VMAT plans were highly conformal, 
demonstrating significant dose reductions to organs at risk 
(OAR). The average median dose to the OARs with VMAT was 
5.4Gy±1.3 and ranged from 2.8Gy in the oral cavity to 8.1Gy 
in the spleen. These are gains of between 25% and 73% 
compared to the conventional parallel-opposed technique 
which had an average median dose of 11.6±0.2. Target 
coverage was similar between the two plans with a D99 of 
10.7Gy±0.4 for conventional TMI and 10.8±0.2Gy for VMAT 
TMI. The VMAT TMI plans had slightly higher global maximums 
than the parallel opposed plans: 13.6Gy±0.1 for VMAT; 
12.6Gy±0.4 for parallel-opposed. The plan verification 
showed good agreement between the Eclipse distributions 
and measured data. The study gamma analysis pass rate 
averaged 99.0 ± 0.5 for all anatomical regions and plans. 
 
 
 
Conclusion: VMAT planning for TMI has the potential to 
significantly reduce doses to OARs, thereby increasing the 
therapeutic ratio, and giving the potential for dose 
escalation. The verification process confirmed good 
agreement between calculated and measured data. VMAT TMI 
is a technically feasible alternative to the standard TMI 
technique but further evaluation is required before clinical 
implementation. 
 
 
 
